| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8433246 | Cancer Epidemiology | 2016 | 7 Pages |
Abstract
The ABCC2 polymorphism, rs8187710 (4544GÂ >Â A), is associated with overall survival in platinum-treated advanced NSCLC patients. Additional studies are needed to evaluate the predictive versus prognostic nature of this relationship, and to explore the functional effect of this polymorphism on the pharmacokinetics of platinum drugs.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Sinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, Xin Qiu, Yonathan Brhane, Qin Kuang, Sharon Marsh, Sevtap Savas, Zhuo Chen, Dangxiao Cheng, Natasha B. Leighl, Glenwood Goss, Scott A. Laurie, Lesley Seymour, Penelope A. Bradbury, Frances A. Shepherd,